Elicio Therapeutics (ELTX) Stock: Buy, Sell, or Hold?
ELTX - Elicio Therapeutics, Inc. Common Stock
$1.85
-0.03 (-1.60%)
▼
5d:
+1.65%
30d:
-21.28%
90d:
-46.99%
HOLD
MODERATE Confidence
Analysis Updated: Oct 7, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When ELTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ELTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ELTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ELTX is currently trading at $1.85, which is considered slightly low relative to its 30-day fair value range of $1.78 to $2.32.
Technical Outlook: Technically, ELTX is in a strong downtrend. Immediate support is located at $1.77, while resistance sits at $2.00.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.67 (+638.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ELTX is in a strong downtrend. Immediate support is located at $1.77, while resistance sits at $2.00.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.67 (+638.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.78 -
$2.32
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (57/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 638.7% below Wall St target ($13.67)
- NEUTRAL: Bottoming setup forming (57/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$1.78 -
$2.32
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.77
Resistance Level
$2.00
Current Trend
Strong Downtrend
Technical data as of
Oct 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.09
Wall Street Target
$13.67
(+638.7%)
Share & Embed Analysis
Last updated: October 08, 2026 1:52 AM ET
Data refreshes hourly during market hours. Next update: 2:52 AM
Data refreshes hourly during market hours. Next update: 2:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 53 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
17 analysts |
$37 | 57 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 54 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
19 analysts |
$18 | 50 HOLD |
|
PTGX
Protagonist Therapeutics… |
STRONG BUY
13 analysts |
$175 | 63 BUY |
